AC

Audere Capital

North America, New York, United States, New York

Description

Audere Capital is an investment firm.

Investor Profile

Audere Capital has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Pre Seed (50%)
  • Series Unknown (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Information Technology
  • Artificial Intelligence (Ai)
  • Biotechnology
  • Clinical Trials
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Audere Capital frequently co-invest with?

Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 1
MV
North America, New York, United States, New York
Co-Investments: 1
Samsung NEXT
North America, California, United States, Mountain View
Co-Investments: 1
Presidio Ventures
North America, California, United States, Santa Clara
Co-Investments: 1
Electric Ant
North America, California, United States, Los Angeles
Co-Investments: 1
TRCM Fund
South America, Magdalena, Colombia, Miami
Co-Investments: 1

Which angels does Audere Capital often collaborate with?

JM
North America, Pennsylvania, United States, Philadelphia
Shared Deals: 1

What are some of recent deals done by Audere Capital?

BioPhy

Philadelphia, Pennsylvania, United States

BioPhy’s patent pending AI brings predictability and quantifiable risk to drug development

Artificial Intelligence (AI)BiotechnologyHealth CareInformation Technology
Pre SeedNov 7, 2023
Amount Raised: $4,500,000
Atropos Health

Palo Alto, California, United States

Atropos Health develops a clinical analytics platform that specializes in evidence-based healthcare.

Clinical TrialsHealth CareInformation TechnologyMedical
Series UnknownSep 21, 2023